Michelle Dawson, MD, AstraZeneca, talks AstraZeneca is Relatively New Six Agents in Phase 1 & another Six in Phase 2 at Annual Meeting 2018.
AstraZeneca is Relatively New Six Agents in Phase 1 & another Six in Phase 2
Michelle Dawson, MD, AstraZeneca, talks AstraZeneca is Relatively New Six Agents in Phase 1 & another Six in Phase 2 at Annual Meeting 2018.